✦ LIBER ✦

T1306 Thalidomide for Treatment of Chronic Gastrointestinal Bleeding from Angiodysplasias: A Pilot Study

✍ Scribed by Kamalaporn, Patarapong; Saravanan, Ramasamy; Cirocco, Maria; May, Gary R.; Kandel, Gabor; Kortan, Paul P.; Marcon, Norman

Book ID: 122946667
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 58 KB
Volume: 134
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)62462-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

S1218 Somatostatin Analogues Are Effecti

S1218 Somatostatin Analogues Are Effective Rescue Therapy for Chronic Bleeding from Gastrointestinal Angiodysplasia: A Meta-Analysis of Prospective Cohort Studies

✍ Collin Brown; Venkataraman Subramanian; Shajan Peter; C. Mel Wilcox 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 74 KB

OC.21.5 LAR OCTREOTIDE IS EFFECTIVE IN C

OC.21.5 LAR OCTREOTIDE IS EFFECTIVE IN CONTROLLING RECURRENT BLEEDING FROM GASTROINTESTINAL ANGIODYSPLASIAS: A RETROSPECTIVE STUDY OF 98 CASES

✍ Compare, D.; Sgamato, C.; Guarracino, M.; Nardone, O.M.; Occhipinti, V.; Iannuzz 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 369 KB

The role of HIF-1, angiopoietin-2, Dll4

The role of HIF-1, angiopoietin-2, Dll4 and Notch1 in bleeding gastrointestinal vascular malformations and thalidomide-associated actions: A pilot in vivo study

✍ Hong Hong TAN; Zhi Zheng GE; Yun Jie GAO; Hui Min CHEN; Jing Yuan FANG; Hai Ying 📂 Article 📅 2011 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 493 KB

1064 Nd:YAG laser for the treatment of c

1064 Nd:YAG laser for the treatment of chronic paronychia: a pilot study

✍ EL-Komy, M. H. M.; Samir, N. 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 141 KB

Treatment of chronic bleeding from gastr

Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study

✍ Albert Tran; Jean-Pierre Villeneuve; Marc Bilodeau; Bernard Willems; Denis Marle 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 51 KB

A pilot study of recombinant interleukin

A pilot study of recombinant interleukin-2 for treatment of chronic hepatitis C

✍ M Pardo; I Castillo; H Oliva; A Fernandez-Flores; R Barcena; M A de Peuter; V Ca 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB 👁 1 views

The optimal and safer interleukin-2 (IL-2) dose for treatment of chronic hepatitis C virus (HCV) infection has been studied in 33 HCV-RNA positive patients with chronic hepatitis C. Patients were randomly allocated to receive 5 days per week during 12 weeks IL-2 doses of: 0.9 MIU (n = 10), 1.8 MIU (